Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial
Authors
Popat, R.Counsell, N.
de Tute, R.
De-Silva, D.
Phillips, Elizabeth H
Cavenagh, J. D.
Adedayo, T.
Braganca, N.
Roddie, C.
Streetly, M.
Schey, S.
Koh, M. B. C.
Crowe, J.
Morris, T. C.
Cook, G.
Smith, P.
Clifton-Hadley, L.
Rabin, N.
Owen, R.
Yong, K.
Affiliation
UCL Cancer Institute, London, UKIssue Date
2021
Metadata
Show full item recordAbstract
NoneCitation
Popat R, Counsell N, de Tute R, De-Silva D, Phillips EH, Cavenagh JD, et al. Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial. Br J Haematol. 2021.Journal
British Journal of HaematologyDOI
10.1111/bjh.17391PubMed ID
33715154Additional Links
https://dx.doi.org/10.1111/bjh.17391Type
Other#Language
enae974a485f413a2113503eed53cd6c53
10.1111/bjh.17391
Scopus Count
Collections
Related articles
- Multiple myeloma with extramedullary disease: impact of autologous stem cell transplantation on outcome.
- Authors: Kumar L, Gogi R, Patel AK, Mookerjee A, Sahoo RK, Malik PS, Sharma A, Thulkar S, Kumar R, Biswas A, Sharma OD, Gupta R
- Issue date: 2017 Oct
- Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
- Authors: Gagelmann N, Eikema DJ, Koster L, Caillot D, Pioltelli P, Lleonart JB, Reményi P, Blaise D, Schaap N, Trneny M, Passweg J, Porras RP, Cahn JY, Musso M, Poiré X, Fenk R, Itälä-Remes M, Pavone V, Fouillard L, Maertens J, Bron D, Pouli A, Schroyens W, Schönland S, Garderet L, Yakoub-Agha I, Kröger N
- Issue date: 2019 Nov
- Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma.
- Authors: Zannetti BA, Tacchetti P, Pantani L, Gamberi B, Tosi P, Rocchi S, Cellini C, Ronconi S, Pezzi A, Mancuso K, Rizzello I, Caratozzolo I, Martello M, Dozza L, Cavo M, Zamagni E
- Issue date: 2017 Dec
- Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival.
- Authors: Lokhorst HM, van der Holt B, Cornelissen JJ, Kersten MJ, van Oers M, Raymakers R, Minnema MC, Zweegman S, Bos G, Schaap N, Wittebol S, de Weerdt O, Ammerlaan R, Sonneveld P
- Issue date: 2015 Dec
- Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry.
- Authors: Thidemann Andersen K, Klausen T, Abildgaard N, Klarskov Andersen M, Frost Andersen N, Christian Frølund U, Helleberg C, Kjeldsen E, Pedersen P, Helm-Petersen S, Svirskaite A, Preiss B, Gimsing P, Juul Vangsted A
- Issue date: 2017 Oct